Organogenesis Holdings (ORGO) Tax Provisions (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Tax Provisions of -$15.3 million for Q1 2026, down 120.71% year-over-year from $74.0 million in Q1 2025, and down 206.95% quarter-over-quarter from $14.3 million in Q4 2025.
Organogenesis Holdings (ORGO) Tax Provisions (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Tax Provisions history runs 10 years deep, the most recent figure standing at -$15.3 million for Q1 2026.
- In Q1 2026, Tax Provisions fell 120.71% year-over-year to -$15.3 million; the TTM figure through Mar 2026 stood at -$3.8 million (up 54.05% YoY), while the FY2025 annual figure was $4.5 million, up 223.58% from the prior year.
- Tax Provisions for Q1 2026 stood at -$15.3 million, down from $14.3 million in the prior quarter.
- The five-year high for Tax Provisions was $14.3 million in Q4 2025, with the low at -$15.3 million in Q1 2026.
- The 5-year median for Tax Provisions is $45000.0 (2022), against an average of -$368647.1.
- The sharpest annual moves came in 2022 and 2023: Tax Provisions surged 1075.38% in 2022, then slumped 3784.44% in 2023.
- Organogenesis Holdings' Tax Provisions stood at $1.3 million in 2022, then slumped by 355.52% to -$3.2 million in 2023, then soared by 179.63% to $2.6 million in 2024, then surged by 455.12% to $14.3 million in 2025, then tumbled by 206.95% to -$15.3 million in 2026.
- Business Quant data shows ORGO's Tax Provisions at -$15.3 million in Q1 2026, $14.3 million in Q4 2025, and -$407000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | 45.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.39 Mn |
| Mar 31, 2026 | -15.32 Mn |
| Dec 31, 2025 | 14.32 Mn |
| Sep 30, 2025 | -407,000.00 |
| Jun 30, 2025 | -2.44 Mn |
| Mar 31, 2025 | -6.94 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2024 | -6.51 Mn |
| Jun 30, 2024 | 2.50 Mn |
| Mar 31, 2024 | -2.24 Mn |
| Dec 31, 2023 | -3.24 Mn |
| Sep 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 3.86 Mn |
| Mar 31, 2023 | -1.66 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 997,000.00 |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | 45,000.00 |
| Dec 31, 2021 | -130,000.00 |
| Sep 30, 2021 | 303,000.00 |